Response to Finsterer: CPT-II deficiency needs to be detected in army personnel by Balasubramanian, M. et al.
This is a repository copy of Response to Finsterer: CPT-II deficiency needs to be detected 
in army personnel.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/133109/
Version: Published Version
Article:
Balasubramanian, M. orcid.org/0000-0003-1488-3695, Jenkins, T.M., Kirk, R.J. et al. (4 
more authors) (2018) Response to Finsterer: CPT-II deficiency needs to be detected in 
army personnel. Molecular Genetics and Metabolism Reports, 16. p. 12. 
https://doi.org/10.1016/j.ymgmr.2018.06.002
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Contents lists available at ScienceDirect
Molecular Genetics and Metabolism Reports
journal homepage: www.elsevier.com/locate/ymgmr
Correspondence
Response to Finsterer: CPT-II deﬁciency needs to be detected in army personnel
Response
Thank you for your insightful and interesting comments to our
manuscript [1] on CPT-II deﬁciency [2].
We read this with interest as we had written this sib-pair up partly
because of the novel variant in CPT2 but also because of the unusual
presentation with the younger sibling (sister) being enrolled in the
army. She joined the army aged 18 and left aged 30 and had frequent
episodes of muscle aches, weakness and dark urine (“like coca cola”).
This often occurred when “tabbing”: 8 mile marches carrying 50 kg
packs or on day-long rugby tournaments. Muscle aches occurred after
6–8miles. The army general practitioner encouraged her to eat more
and to drink more ﬂuids, which may well have helped prevent acute
renal failure.
We agree with your conclusion that army personnel should have a
thorough history and assessment done in order to ensure early identi-
ﬁcation of personnel with neuromuscular/metabolic disorders. Also,
when an army personnel presents with symptoms similar to our patients
after strenuous exercise, fatty acid oxidation disorders (FAOD) should
be considered as a possible diagnosis and excluded through biochemical
testing [3].
Metabolic myopathies remain a challenging diagnosis especially in
non-specialist settings, due to their rarity, intermittent presentation,
and frequent lack of clinical signs in between attacks. In addition, it is
well recognised that rhabdomyolysis may occur following extreme ex-
ercise in individuals without identiﬁable metabolic myopathy, although
this is generally not recurrent.
With regards to the oﬀspring recurrence risk for CPT-II deﬁciency, it
is useful to point out that Carnitine palmitoyltransferase II (CPT II)
deﬁciency is inherited in an autosomal recessive manner. The lethal
neonatal form of CPT-II deﬁciency is usually as a result of homozygous
CPT2 pathogenic null variants leading either to truncation of the pro-
tein or to mRNA degradation. The myopathic form of CPT-II deﬁciency
as reported in our family is usually a result of homozygous or com-
pound heterozygous missense pathogenic variants in CPT2, most no-
tably the common p.Ser113Leu variant which accounts for over 60% of
cases.
All the oﬀspring of a patient with myopathic CPT-II deﬁciency
would be ‘unaﬀected’ carriers but should not have the full blown fea-
tures of the condition unless the patient's partner is also a carrier. As
such manifesting carriers are rarely reported with severe features of
CPT-II deﬁciency. However, if there is consanguinity, then there needs
to be a low threshold to oﬀer carrier testing for the familial variants as
identiﬁed in the index case.
Nevertheless, we agree that the main take home message is to
consider a FAOD in patients with unexplained muscle weakness and
myalgia after excess exercise. Raising awareness of this presentation
was a goal of writing the report. There should be a low threshold for a
through neurological/metabolic work-up and conﬁrmatory genetic
testing to clarify diagnosis and oﬀspring recurrence risk in such cir-
cumstances.
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